Latest evidence on sexual health screening published
New resources outlining the latest evidence on sexual health screening have been released by Public Health England (PHE).
The package reveals the latest evidence on the impact and economics of opportunistic chlamydia screening, and HIV screening and testing.
For both subjects, PHE has produced:
- Evidence Summaries: a full review of the latest evidence on opportunistic chlamydia screening and HIV screening and testing including cost-efficacy, impact, acceptability etc.
- Leaders’ Briefings: covering frequently asked questions and considerations for local action.
Dr Anthony Nardone, consultant epidemiologist in PHE’s HIV team, said: "Currently, in the UK around half of all HIV diagnoses are still made late, impacting health outcomes for those affected and driving ongoing transmission. There is an opportunity for all relevant stakeholders, like local authorities, clinical commissioning groups, NHS England teams and providers, to collaborate to reduce late HIV diagnoses.
"Interventions to reduce the number of people living with undiagnosed HIV, around 22,000 in the UK, are also needed. We believe embedding HIV screening and testing in local medical and community services are an essential element of local sexual health services. We encourage all areas to ensure that this is in place, and hope the evidence summary will help inform local planning."
The National Chlamydia Screening Programme (NCSP) recommends screening sexually active young adults, annually or on change of partner, in primary care or sexual health consultations.
PHE believes local authorities now have an opportunity to build on a decade of progress in tackling chlamydia, by ensuring good quality opportunistic screening remains easily accessible to young adults moving forward.